Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • SWKS vs MRNA✓SelectedUSD · MRNASWKS vs MRNA performance historyLatest closeAs of-0.10%11/13
Stock and ETF performance explorer

SWKS vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+36.2%
MRNA return
+755.5%
Excess return
-719.3%
Maximum drawdown
-32.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-0.1%-3.4%+3.3%-0.1%
7D+9.4%-12.1%+21.6%+9.6%
30D+17.0%-1.3%+18.3%+16.9%
3M+28.9%+250.9%-222.0%+25.4%
6M+33.1%+343.0%-309.9%+26.6%
YTD+44.8%+657.4%-612.7%+27.3%
1Y+36.2%+794.9%-758.7%+13.9%
All+36.2%+755.5%-719.3%+13.9%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling